Company Filing History:
Years Active: 2019
Title: Sylwia Stachura: Innovator in Immunology
Introduction
Sylwia Stachura is a prominent inventor based in Flemington, NJ (US). She has made significant contributions to the field of immunology through her innovative research and development of novel compounds.
Latest Patents
Sylwia holds a patent for "Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses." This patent describes compounds of formula I or a stereoisomer or pharmaceutically-acceptable salt thereof, which are useful in modulating IL-12, IL-23, and/or IFNα by acting on Tyk-2 to cause signal transduction inhibition. This work highlights her expertise in developing therapeutic agents that can impact immune responses.
Career Highlights
Sylwia is currently employed at Bristol-Myers Squibb Company, where she continues to advance her research in immunology. Her work has been instrumental in the development of new treatments that target critical pathways in immune modulation.
Collaborations
Throughout her career, Sylwia has collaborated with notable colleagues, including David S. Weinstein and Ryan M. Moslin. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Sylwia Stachura is a dedicated inventor whose work in immunology is paving the way for new therapeutic approaches. Her contributions, particularly in the modulation of immune responses, are significant in the ongoing quest for effective treatments.